These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 32891310)

  • 1. Going Home: Access for Home Modalities.
    Gardezi AI; Sequeira A; Narayan R
    Adv Chronic Kidney Dis; 2020 May; 27(3):253-262. PubMed ID: 32891310
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Costs Attributable to Arteriovenous Fistula and Arteriovenous Graft Placements in Hemodialysis Patients with Medicare coverage.
    Nordyke RJ; Reichert H; Bylsma LC; Jackson JJ; Gage SM; Fryzek J; Roy-Chaudhury P; Lithgow T
    Am J Nephrol; 2019; 50(4):320-328. PubMed ID: 31434095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The financial implications for Medicare of greater use of peritoneal dialysis.
    Neil N; Guest S; Wong L; Inglese G; Bhattacharyya SK; Gehr T; Walker DR; Golper T
    Clin Ther; 2009 Apr; 31(4):880-8. PubMed ID: 19446160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lifetime cost-effectiveness analysis of first-line dialysis modalities for patients with end-stage renal disease under peritoneal dialysis first policy.
    Wong CKH; Chen J; Fung SKS; Mok M; Cheng YL; Kong I; Lo WK; Lui SL; Chan TM; Lam CLK
    BMC Nephrol; 2020 Feb; 21(1):42. PubMed ID: 32019528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The United States' perspectives on home dialysis.
    Qamar M; Bender F; Rault R; Piraino B
    Adv Chronic Kidney Dis; 2009 May; 16(3):189-97. PubMed ID: 19393969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost analysis of ongoing care of patients with end-stage renal disease: the impact of dialysis modality and dialysis access.
    Lee H; Manns B; Taub K; Ghali WA; Dean S; Johnson D; Donaldson C
    Am J Kidney Dis; 2002 Sep; 40(3):611-22. PubMed ID: 12200814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The changing landscape of home dialysis in the United States.
    Rivara MB; Mehrotra R
    Curr Opin Nephrol Hypertens; 2014 Nov; 23(6):586-91. PubMed ID: 25197946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Economic evaluation of dialysis therapies.
    Klarenbach S; Manns B
    Semin Nephrol; 2009 Sep; 29(5):524-32. PubMed ID: 19751898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Medicare cost of renal dialysis. Evidence from a statistical cost function.
    Dor A; Held PJ; Pauly MV
    Med Care; 1992 Oct; 30(10):879-91. PubMed ID: 1405794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Direct and indirect costs of end-stage renal disease patients in the first and second years after initiation of nocturnal home haemodialysis, hospital haemodialysis and peritoneal dialysis.
    Wong CKH; Chen J; Fung SKS; Mok MMY; Cheng YL; Kong I; Lo WK; Lui SL; Chan TM; Lam CLK
    Nephrol Dial Transplant; 2019 Sep; 34(9):1565-1576. PubMed ID: 30668781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patient education and access of ESRD patients to renal replacement therapies beyond in-center hemodialysis.
    Mehrotra R; Marsh D; Vonesh E; Peters V; Nissenson A
    Kidney Int; 2005 Jul; 68(1):378-90. PubMed ID: 15954930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medicare Costs Associated With Arteriovenous Fistulas Among US Hemodialysis Patients.
    Thamer M; Lee TC; Wasse H; Glickman MH; Qian J; Gottlieb D; Toner S; Pflederer TA
    Am J Kidney Dis; 2018 Jul; 72(1):10-18. PubMed ID: 29602630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost of Dialysis Therapy by Modality in Manitoba.
    Beaudry A; Ferguson TW; Rigatto C; Tangri N; Dumanski S; Komenda P
    Clin J Am Soc Nephrol; 2018 Aug; 13(8):1197-1203. PubMed ID: 30021819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reducing hemodialysis costs: conventional and quotidian home hemodialysis in Canada.
    McFarlane PA
    Semin Dial; 2004; 17(2):118-24. PubMed ID: 15043613
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The 2011 ESRD prospective payment system: perspectives of a home dialysis patient advocate.
    Peckham B
    Am J Kidney Dis; 2011 Apr; 57(4):559-61. PubMed ID: 21333429
    [No Abstract]   [Full Text] [Related]  

  • 16. Mortality, Hospitalization, and Technique Failure in Daily Home Hemodialysis and Matched Peritoneal Dialysis Patients: A Matched Cohort Study.
    Weinhandl ED; Gilbertson DT; Collins AJ
    Am J Kidney Dis; 2016 Jan; 67(1):98-110. PubMed ID: 26319755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adverse technical events in home hemodialysis.
    Tennankore KK; d'Gama C; Faratro R; Fung S; Wong E; Chan CT
    Am J Kidney Dis; 2015 Jan; 65(1):116-21. PubMed ID: 25441436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incident Dialysis Access in Patients With End-Stage Kidney Disease: What Needs to Be Improved.
    Moist LM; Lok CE
    Semin Nephrol; 2017 Mar; 37(2):151-158. PubMed ID: 28410649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Utilization of CMS pre-ESRD Kidney Disease Education services and its associations with the home dialysis therapies.
    Shukla AM; Bozorgmehri S; Ruchi R; Mohandas R; Hale-Gallardo JL; Ozrazgat-Baslanti T; Orozco T; Segal MS; Jia H
    Perit Dial Int; 2021 Sep; 41(5):453-462. PubMed ID: 33258420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Debate: Should dialysis at home be mandatory for all suitable ESRD patients?: home-based dialysis therapies are the second choice after transplantation.
    Lewicki MC; Polkinghorne KR; Kerr PG
    Semin Dial; 2015; 28(2):147-54. PubMed ID: 25481976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.